NCT01748552View on ClinicalTrials.gov

A Study of LY2922083 in Healthy Participants and Participants With Diabetes

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

August 31, 2013

Study Completion Date

August 31, 2013

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Placebo

Administered orally as capsules

DRUG

LY2922083

Administered orally as capsules

Trial Locations (1)

117597

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Singapore

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT01748552 - A Study of LY2922083 in Healthy Participants and Participants With Diabetes | Biotech Hunter | Biotech Hunter